A critical advance in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently disabled in several kinds of cancer, causing https://ariabookmarks.com/story7843498/mini-antibodies-restore-tumor-suppressor-p53-the-new-pathway-for-tumor-treatment